ResearcherIuliu Hațieganu University of Medicine and PharmacyNo recent work listed
Tudor–Eliade Ciuleanu
Matched on ORCID iD 0009-0006-5351-4234; OpenAlex author ID A5001591653. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2012: 1 paper · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper
Papers 3
- A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients. Co-author DOI 10.1186/s12885-017-3131-x↗
- Dose escalation to rash for erlotinib plus gemcitabine for metastatic pancreatic cancer: the phase II RACHEL study. Last author DOI 10.1038/bjc.2014.494↗
- A phase II open-label randomized study to assess the efficacy and safety of selumetinib (AZD6244 [ARRY-142886]) versus capecitabine in patients with advanced o… Co-author DOI 10.1007/s10637-011-9687-4↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Dick J. Richel · 1 shared paper, 2017 · strength 0.05
- Donald Richards · 1 shared paper, 2017 · strength 0.05
- Berta Laquente · 1 shared paper, 2017 · strength 0.05
- George Kim · 1 shared paper, 2017 · strength 0.05
- Emiliano Calvo Aller · 1 shared paper, 2017 · strength 0.05
- Stefano Cascinu · 1 shared paper, 2017 · strength 0.05
- Daniel D. Von Hoff · 1 shared paper, 2017 · strength 0.05
- Gyorgy Bodoky · 1 shared paper, 2012 · strength 0.03
- Niall Christopher Tebbutt · 1 shared paper, 2012 · strength 0.03
- David Robert Spigel · 1 shared paper, 2012 · strength 0.03
- J-L Van Laethem · 1 shared paper, 2014 · strength 0.03
- Chiun Hsu · 1 shared paper, 2014 · strength 0.03
- Giuseppe Aprile · 1 shared paper, 2014 · strength 0.03
- Salomon Marcello Stemmer · 1 shared paper, 2014 · strength 0.03
- Malcolm J. Moore · 1 shared paper, 2014 · strength 0.03
- Eric Van Cutsem · 1 shared paper, 2014 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.